Lumoxiti (moxetumomab pasudotox-tdfk) — Uses, Dosage, Side Effects & Safety

Drug class: Antineoplastic agent; CD22-directed cytotoxin

Overview

Lumoxiti is a prescription medicine used to treat adults with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including a purine nucleoside analog. It is not used for other types of leukemia or cancers. Lumoxiti works by targeting a protein called CD22 found on the surface of cancerous B-cells. It delivers a toxin directly to these cells, helping to kill them while sparing most healthy cells. This targeted approach may help reduce some of the side effects seen with traditional chemotherapy. Key points for patients: Lumoxiti is given by intravenous infusion in a hospital or clinic setting. It is important to stay well hydrated and to report any unusual symptoms to your healthcare provider. This medication can cause serious side effects, so close monitoring is required during and after treatment.

Therapeutic uses

  • Hairy cell leukemia (HCL)
  • Relapsed or refractory hairy cell leukemia (HCL)
  • Hairy cell leukemia (HCL) after at least two prior systemic therapies, including a purine analog

Common side effects

  • Capillary leak syndrome
  • Hemolytic uremic syndrome
  • Infusion-related reactions
  • Nausea
  • Fatigue
  • Peripheral edema
  • Pyrexia
  • Hypoalbuminemia

Frequently Asked Questions about Lumoxiti

What is Lumoxiti used for?

Lumoxiti is used to treat adults with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior treatments, including a purine nucleoside analog.

How is Lumoxiti given?

Lumoxiti is given as an intravenous infusion by a healthcare professional in a hospital or clinic setting.

What are the most serious side effects of Lumoxiti?

The most serious side effects include capillary leak syndrome, hemolytic uremic syndrome, severe infections, and infusion-related reactions.

Can Lumoxiti be used in children?

No, Lumoxiti is not recommended for use in children under 18 years, as safety and efficacy have not been established.

Do I need to take any special precautions while on Lumoxiti?

Yes, stay well hydrated, monitor for signs of infection or swelling, and attend all scheduled blood tests and appointments.

What should I do if I miss a dose?

Contact your healthcare provider immediately. Do not attempt to self-administer or reschedule the dose on your own.

Can I receive vaccines while on Lumoxiti?

You should avoid live vaccines during treatment with Lumoxiti. Discuss all vaccinations with your healthcare provider.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.